Toronto, Ontario--(Newsfile Corp. - September 29, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
Startup Receives $350K Grand Prize for Real-Time, Wearable Stroke Monitor for Older Americans Living with High Stroke Risk LOS ANGELES...
BOHEMIA, NY and PITTSBURGH, PA / ACCESSWIRE / September 29, 2021 / Scientific Industries, Inc. (OTCQB:SCND) announced today that it...
OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced an asset...
WASHINGTON--(BUSINESS WIRE)--#GovWaste--Today, Citizens Against Government Waste (CAGW) released a new Issue Brief, “Government-Run Healthcare Will Harm Patients and Eliminate Consumer...
LONDON, UK / ACCESSWIRE / September 29, 2021 / UTILITY therapeutics Ltd., a biotechnology company focused on the US development...
STOCKHOLM, SE / ACCESSWIRE / September 29, 2021 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) announces that for the second...
EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
Denali to present results from Phase 1 healthy volunteer study of EIF2B activator DNL343Sanofi to present Phase 2 study plans...
No serious adverse events or dose-limiting toxicities observed to date Efficacy signals in the mid-dose cohort provide initial support for...
Rapid reset of immune system can provide marked benefits in clinical settings where patients are significantly immunocompromisedPARIS, Sept. 29, 2021...
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP)...
Nes-Ziona, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Award for “Spray Away” Campaign seeking to drive patient and provider awareness for the novel nasal spray treatment of symptoms...
MONTREAL, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the...
Subpopulation analysis of 74 patients from ongoing Phase 3 FURI study demonstrated similar efficacy against multiple serious fungal infectionsJERSEY CITY,...
MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept....
Data from two different studies benchmark Duet’s proprietary bifunctional oligonucleotides against immune checkpoint inhibitors (“Checkpoint Inhibitors”) in lymphoma and prostate...
BURBANK, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company...
Trial is expected to enroll 15 boys with DMD amenable to exon 53 skipping First systemically administered therapeutic candidate with...